Royal DSM has announced Chris Goppelsroeder, president and CEO of DSM Nutritional Products (DNP) and member of the DSM executive committee, will retire and leave the company this April. Dimitri de Vreeze, co-CEO of DSM, will step into Goppelsroeder’s DNP leadership role in his capacity as COO.
Goppelsroeder first joined DSM in 2003, when the company acquired Roche Holding’s vitamin division. In 2013, he became president and CEO of DNP. Over the years, he has led DSM’s business to growth, and transformed the company’s operating model with the adoption of a customer-centric approach. He was also instrumental in DNP’s growth organically as well as through acquisitions, including Glycom and Erber Group. In addition, Goppelsroeder played a crucial role in the development of innovation projects such as Clean Cow/Bovaer, Veramaris, and DSM’s new moves in the space of precision and personalised nutrition.
Geraldine Marcheet and de Vreeze, co-CEOs, commented: “Chris has been a key and valued leader for DSM, and we are grateful for his dedication and the contributions he has made in transforming DSM to where we are today. We will be sad to say goodbye to a great colleague and friend who has built a fantastic leadership team. Chris leaves a tremendous legacy and, on behalf of the entire company, we wish him all the best for his well-deserved retirement.”